High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry

Chakravarthy Narasimhan1, Henryk Mach, Mohammed Shameem

  • 1Sterile Product Development, Merck Research Laboratories, Summit, NJ, USA.

Therapeutic Delivery
|August 21, 2012
PubMed